前列腺癌治疗飞速发展: 病名，药名，人名，临床实验名

CSPC

M0 CSPC - embark study

CRPC

Non-metastatic castration-resistant prostate cancer (nmCRPC)

Metastatic hormone-sensitive prostate cancer (mHSPC), ARASENS study

PCWG3 criteria

Androgen receptor pathway inhibitors (ARPis) 

LOH (16)

HRRm-homologous recombination repair gene mutation

OAR-organ at risk

PSADT, PSA doubling time